COLL News and Press, Collegium Pharmaceutical Inc. From 02/06/20

Collegium Pharmaceutical (NASDAQ: COLL ) +8.3% after-hours on news it agrees to acquire the U.S. rights to the Nucynta franchise from Assertio Therapeutics (NASDAQ: ASRT ) for $375M; ASRT +56.7% . More news on: Collegium Pharmaceutical, Inc., Assertio Therapeutics, Inc., Healthcare st...

– Financially Transformative Acquisition – – Expected to Significantly Grow Net Income, EBITDA and Operating Cash Flows – – Structure of the Financing Allows for Rapid De-Leveraging – – Provides Financial Flexibility to Pursue F...

NEW HAVEN, Conn. , Jan. 31, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced the appointment of Michael Heffernan to its Board of Directors ("Board"). Mr. Heffernan is a seasoned biopharmaceutical leader with over 25 years of commer...

Source: GraycellAdvisors.com Systematic Investing Systematic investing has become a growing part of the stock market. The investing style refers to a rules-based algorithmic system that limits or eliminates individual judgments and biases towards portfolio selection and adjustments. ...

Today, we will be studying why Collegium Pharmaceutical ( COLL ) is an attractive pick in 2020, despite being an opioid player. Company overview Collegium Pharmaceutical is a specialty pharmaceutical company with a focus on developing and commercializing pain management medications. The ...

There's plenty of interesting biotech news floating about for investors to consider, but there was one announcement this week that might have slipped under your radar. Collegium Pharmaceutical (NASDAQ: COLL) , a small-cap drug developer, announced updated guidance figures for 2020, surprisi...

Collegium Pharmaceutical (NASDAQ: COLL ) provides its 2020 outloo k. More news on: Collegium Pharmaceutical, Inc., Healthcare stocks news, Read more ...

– Xtampza ® ER Revenues Expected in the Range of $150.0 Million to $160.0 Million for 2020 – STOUGHTON, Mass., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in re...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on multiple discriminant analysis ((MDA)) breakout selections over more than five years. This subset of the different portfolios I regularly analyze has now reached 135 weeks of public selections as part of t...

The Netflix Prize The Netflix Prize was a competition begun in 2006 to predict user ratings for films. Competitors were given ratings scrubbed of information about the users and were challenged to find, using machine-learning methods, an algorithm based only on the raw data. Netflix provid...